A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

NCT01823016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: JNJ-38518168

Sponsor

Janssen Research & Development, LLC